Aemetis, Inc. (NASDAQ:AMTX) Receives Average Recommendation of “Moderate Buy” from Brokerages

Aemetis, Inc. (NASDAQ:AMTX) has earned an average recommendation of “Moderate Buy” from the five analysts that are covering the company, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month target price among brokers that have covered the stock in the last year is $12.95.

AMTX has been the topic of several recent research reports. Ascendiant Capital Markets dropped their price objective on shares of Aemetis from $20.00 to $19.00 and set a “buy” rating on the stock in a research note on Tuesday, September 3rd. StockNews.com raised shares of Aemetis to a “sell” rating in a report on Wednesday, July 31st. Truist Financial reaffirmed a “hold” rating and issued a $3.50 price objective (down previously from $4.00) on shares of Aemetis in a report on Wednesday, July 31st. HC Wainwright reissued a “buy” rating and set a $28.00 target price on shares of Aemetis in a research note on Friday, August 2nd. Finally, UBS Group decreased their price target on Aemetis from $8.25 to $7.75 and set a “buy” rating on the stock in a research note on Monday, August 19th.

Institutional Trading of Aemetis

Several large investors have recently bought and sold shares of the company. SG Americas Securities LLC acquired a new position in shares of Aemetis during the 1st quarter worth $60,000. Hutchinson Capital Management CA acquired a new position in Aemetis during the second quarter worth about $70,000. State Board of Administration of Florida Retirement System purchased a new stake in shares of Aemetis in the first quarter valued at about $84,000. Rhumbline Advisers grew its position in shares of Aemetis by 2,837.1% in the second quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock valued at $157,000 after purchasing an additional 50,528 shares during the last quarter. Finally, Bank of New York Mellon Corp purchased a new position in shares of Aemetis during the 2nd quarter worth approximately $306,000. Institutional investors and hedge funds own 27.02% of the company’s stock.

Aemetis Price Performance

AMTX stock opened at $3.00 on Wednesday. The company has a market cap of $133.19 million, a price-to-earnings ratio of -2.56 and a beta of 1.24. The company has a fifty day moving average price of $2.55 and a 200 day moving average price of $3.18. Aemetis has a 12 month low of $2.10 and a 12 month high of $7.03.

Aemetis (NASDAQ:AMTX) last announced its earnings results on Thursday, August 1st. The specialty chemicals company reported ($0.66) earnings per share for the quarter, missing the consensus estimate of ($0.41) by ($0.25). The firm had revenue of $66.56 million for the quarter, compared to analyst estimates of $75.37 million. During the same period last year, the business earned ($0.68) EPS. As a group, analysts anticipate that Aemetis will post -2.07 earnings per share for the current year.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.